Syed Haider

40PUBLICATIONS

308CO-AUTHORS

Health and ecological risk assessmentPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (40)

Sort by Publication Date:

|Jul 10, 2026

The PRECISE European initiative for cancer-vulnerability mapping and prediction.

|Apr 28, 2026

A Randomized, Phase II Clinical Trial of FLT-PET and FDG-PET for Early Response Assessment of Neoadjuvant Systemic Therapy in Triple Negative Breast Cancer.

|Mar 12, 2026

Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitors.

Callum Walker, Gabriel Kollarovic, Daniel Weekes

|Mar 06, 2026

Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy.

Winnie Fernando, Jarama Clucas, Alberto Rizzo

|Feb 18, 2026

LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

Renée L Flaherty, Flavia Hughes, George Sflomos

|Oct 23, 2025

An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer.

Alicia M Chenoweth, Anthony Cheung, Jitesh Chauhan

Pageof 7

Frequent Collaborators

13 joint publications

Christopher J Lord

11 joint publications

Andrew Tutt

Stephen Pettitt

Rachael Natrajan

John Alexander

Jyoti S Choudhary

Clare M Isacke

Anita Grigoriadis

Adrian L Harris

Theodoros Roumeliotis

Frequent Collaborators

13 joint publications

Christopher J Lord

11 joint publications

Andrew Tutt

7 joint publications

Stephen Pettitt

7 joint publications

Rachael Natrajan